PANSI PATEL: Open Payments
NPI 1548897788 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,618 in 140 payments from 17 companies in 2025. Trend: 2023 $2,923 · 2024 $3,134 · 2025 $2,618
Food & beverage: $2,518Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $805 |
| AstraZeneca Pharmaceuticals LP | 14 | $324 |
| Janssen Biotech, Inc. | 10 | $274 |
| Amgen Inc. | 12 | $190 |
| GlaxoSmithKline, LLC. | 16 | $171 |
| ANI Pharmaceuticals, Inc. | 9 | $160 |
| Novartis Pharmaceuticals Corporation | 10 | $152 |
| UCB, Inc. | 7 | $119 |
| Forte Bio-Pharma LLC | 7 | $116 |
| Mallinckrodt Hospital Products Inc. | 4 | $93 |
Products named: RINVOQ, SAPHNELO, SKYRIZI, TREMFYA, BENLYSTA, PURIFIED CORTROPHIN GEL, COSENTYX, Bimzelx.
Industry payments across SC — which companies pay providers there.
